GlassScriptPhysician profile
Luke A Edwards
NPI 1922361294
$2,986.78
in general payments reported to CMS, 2019-2025
34 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $69.68 · 2021: $149 · 2022: $309 · 2023: $342 · 2024: $228 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,040 · Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,039.96 |
| Food and Beverage | $992.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,363.93 | 2025 | |
| Boston Scientific Corporation | $310.63 | 2019-2025 | Lithovue, Tria Firm, Watchman Access System |
| Coloplast Corp | $151.31 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $145.97 | 2019-2023 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.33 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $135.54 | 2020-2023 | Dificid |
| Intercept Pharmaceuticals, INC. | $82.37 | 2019-2022 | |
| Abbvie INC. | $76.24 | 2022-2023 | Creon, Linzess |
| Urovant Sciences INC | $53.27 | 2022 | |
| Daiichi Sankyo INC. | $45.29 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $42.32 | 2020-2021 | |
| Edwards Lifesciences Corporation | $37.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $26.98 | 2019 | |
| Csl Behring | $24.95 | 2019 | |
| Hollister Incorporated | $24.43 | 2025 | New Image |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $24.21 | 2019 | |
| Portola Pharmaceuticals, LLC | $23.84 | 2019 | |
| Neotract INC. | $22.64 | 2019 | |
| Janssen Biotech, INC. | $21.56 | 2025 | |
| Teleflex LLC | $20.23 | 2023 | Urolift |
| Pfizer INC. | $20.22 | 2025 | |
| Olympus America INC. | $19.18 | 2023 | Hd Camera Head, Uretero-Reno Videoscope, Olympus |
| Sumitomo Pharma America, INC. | $16.24 | 2023 | Gemtesa |
| Redhill Biopharma INC. | $16.23 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.85 | 2023 | |
| Endo Pharmaceuticals INC. | $15.31 | 2023 | Xiaflex |
| Medtronic, INC. | $15.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $14.54 | 2023 | Dupixent |
| Convatec INC. | $13.38 | 2019 | |
| Dentsply Ih Ab | $13.22 | 2023 | Lofric |
| Abc Home Medical Supply, INC. | $13.03 | 2022 | |
| Palette Life Sciences, INC. | $12.71 | 2023 | |
| Vivus LLC | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.